Tuesday, 25 Jul 2017

TNF inhibitor

Datesort ascending Type Title Save
17 Feb 2017 Social New Bluetooth device and App to monitor the temperature of your biologic therapy. KEEP IT OUT OF THE VEGGIE CRISPER https://t.co/yghCLkUFIq
17 Feb 2017 Social RT @DrRachelTate: Biosimilars - noninferior in switch trial from IFX and CT-P13 @RheumNow @RWCSmtg https://t.co/bBAaUWHGt1
15 Feb 2017 Social RT @DrRachelTate: Biosimilars - noninferior in switch trial from IFX and CT-P13 @RheumNow @RWCSmtg https://t.co/bBAaUWHGt1
03 Feb 2017 Social infliximab 4 wks before TKA or THA did not increase risk of infection https://t.co/0PPLyNnNP5 @CCalabreseDO @HealioRheum @medpagetoday
31 Jan 2017 News Is the Jury Still Out on Triple Therapy vs. MTX + TNF inhibitor?
24 Jan 2017 Social Janssen has applied to FDA for new indications (AS, PsA) for golimumab based on GO-ALIVE, GO-VIBRANT trials https://t.co/qTZMJtWmya
12 Jan 2017 Social ARTIS #RA registry shows those initiating TNFi within 3 yrs of onset, double their odds of returning to work. https://t.co/WytSlSYRj1
04 Jan 2017 Social TNF inhibitor survival in 2687 Finnish pts - 27% discontinue TNFi in 12 mos. Worse w/ CZP & Rem, better w/ combo MTX https://t.co/13vJxWGWCs
02 Jan 2017 News Cautious Optimism for Biosimilars in Rheumatology
02 Jan 2017 Social Systematic review of >1000 IBD pts Tx w/ biosimilar CT-P13 v Remicade shows no difference in efficacy, safety, ADAbs https://t.co/BElV5shX03
21 Dec 2016 Social Janssen has filed for Simponi (golimumab) approvals for psoriatic athritis and anklylosing spondylitis https://t.co/dBv1o5WupX
13 Dec 2016 News Supreme Court Declines Biosimilar Patent Dispute
12 Dec 2016 News Random Drug Levels and Anti-Drug Antibodies Predict Rheumatoid Outcomes
05 Dec 2016 News Key Lessons from the TNF Inhibitor Head-to-Head EXXELERATE Study
01 Dec 2016 Social Good overview TB risk on TNFi (0.79%), all tx & recovered but 1 death. 76% restarted TNFi with only 1.3% TB recurr https://t.co/DQbeFmWmLX
21 Nov 2016 Social Retrosp study of Humira in 40 pts (66 eyes) w/ Behcets ocular dz showed signif less flares (200-->8.5/100PY) w/ ADA https://t.co/t8ldrYptGD
17 Nov 2016 Social RT @emartinmola: No chance for TNF blockers to improve Sjogren's syndrome https://t.co/B8HQF6QGzq
31 Oct 2016 Slide of the day 3 New TNF Inhibitor Biosimilars Approved in 2016
26 Oct 2016 Social Panel of neutrophil genes may be highly predictive of TNFi response in RA pts; CMPK2, IFIT1B, and RNASE3 https://t.co/4jjaHdgGgQ
26 Oct 2016 Social In Ireland, Pfizer has cut the price of Enbrel to match the price of Benepali - an ETN biosimilar. https://t.co/AKdp5bhHoc